Selectis Health (GBCS) Receivables - Net (2013 - 2025)

Selectis Health (GBCS) has 12 years of Receivables - Net data on file, last reported at $2.3 million in Q4 2025.

• Quarterly Receivables - Net fell 12.98% year-over-year to $2.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.3 million (down 12.98% YoY) and the FY2025 annual result came in at $2.3 million, down 12.98% from the prior year.
• Receivables - Net fell to $2.3 million in Q4 2025 per GBCS's latest filing, from $3.2 million in the prior quarter.
• The five-year high for Receivables - Net was $4.7 million in Q2 2022, with the low at $1.8 million in Q1 2024.
• Average Receivables - Net over 5 years is $2.9 million, with a median of $2.9 million recorded in 2023.
• Year-over-year, Receivables - Net surged 133.18% in 2021 and slumped 45.19% in 2023.
• Selectis Health's Receivables - Net stood at $3.5 million in 2021, then fell by 17.17% to $2.9 million in 2022, then retreated by 28.0% to $2.1 million in 2023, then rose by 25.12% to $2.6 million in 2024, then retreated by 12.98% to $2.3 million in 2025.
• Business Quant data shows GBCS's Receivables - Net at $2.3 million in Q4 2025, $3.2 million in Q3 2025, and $3.0 million in Q2 2025.